27 Feb 2026 | 5 Mins Read
Lupin receives USFDA establishment inspection report for Goa facility
Flipitmoney
Lupin Ltd. received an establishment inspection report with a satisfactory voluntary action indicated (VAI) classification from the US FDA for its Goa facility after an inspection from November 10, 2025, to November 21. This outcome reflects Lupin's focus on quality excellence and regulatory compliance. Lupin earlier received USFDA approval for its Brivaracetam oral solution ANDA.